Variant report
Variant | esv3370353 |
---|---|
Chromosome Location | chr7:16333649-16334141 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:16333849..16337358-chr7:16346440..16349011,3 | K562 | blood: | |
2 | chr7:16328727..16330491-chr7:16332176..16334941,2 | K562 | blood: | |
3 | chr7:16328904..16333802-chr7:16457982..16461920,4 | K562 | blood: | |
4 | chr7:16332203..16333821-chr7:16335558..16338156,2 | K562 | blood: | |
5 | chr7:16332474..16335082-chr7:16341108..16343730,3 | K562 | blood: | |
6 | chr7:16333754..16335349-chr7:16345715..16348508,2 | K562 | blood: | |
7 | chr7:16333997..16336395-chr7:16337300..16340770,3 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000214960 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs138380718 | chr7:16333657-16333658 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs549381864 | chr7:16333676-16333677 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs73065159 | chr7:16333677-16333678 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs529069845 | chr7:16333700-16333701 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs550543401 | chr7:16333714-16333715 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs569598003 | chr7:16333721-16333722 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs186842350 | chr7:16333733-16333734 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs17460152 | chr7:16333755-16333756 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs191687663 | chr7:16333756-16333757 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs73298620 | chr7:16333783-16333784 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs534209397 | chr7:16333822-16333823 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs549634114 | chr7:16333837-16333838 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs61666208 | chr7:16333858-16333859 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs375162282 | chr7:16333862-16333863 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs538429325 | chr7:16333911-16333912 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs556432826 | chr7:16333918-16333919 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs145162141 | chr7:16333929-16333930 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs371739132 | chr7:16333937-16333938 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs182306999 | chr7:16333953-16333954 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs557453237 | chr7:16333954-16333955 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs572482534 | chr7:16333960-16333961 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs187356054 | chr7:16334009-16334010 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs200075247 | chr7:16334094-16334095 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs200645374 | chr7:16334096-16334097 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs77777049 | chr7:16334104-16334105 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Melanoma | 17363583 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Heart disease | 21282601 | CNVD |
Rubinstein-Taybi syndrome | 22470819 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Non-syndromic sensorineural hearing loss | 22570644 | CNVD |
Bladder cancer | 21909424 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 22522925 | CNVD |
Schizophrenia | 19805367 | CNVD |
Autism | 20808228 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:16313600-16348200 | Weak transcription | Gastric | stomach |
2 | chr7:16332800-16334000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
3 | chr7:16332800-16334200 | Enhancers | NHEK | skin |
4 | chr7:16333200-16334000 | Enhancers | Muscle Satellite Cultured Cells | -- |
5 | chr7:16333400-16333800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
6 | chr7:16333400-16334200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
7 | chr7:16333400-16349000 | Weak transcription | Psoas Muscle | Psoas |
8 | chr7:16333600-16333800 | Flanking Active TSS | HMEC | breast |
9 | chr7:16333600-16336400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
10 | chr7:16333800-16334000 | Enhancers | HMEC | breast |